查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1870873

依治療類型、技術、最終用戶、應用領域和分銷管道分類的塑形市場—2025-2032年全球預測

Body Contouring Market by Procedure Type, Technology, End User, Application Area, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，塑形市場規模將達到 9.8314 億美元，複合年成長率為 12.34%。

關鍵市場統計數據
基準年 2024 3.8748億美元
預計年份：2025年 4.3635億美元
預測年份 2032 9.8314億美元
複合年成長率 (%) 12.34%

本書簡明扼要地介紹了不斷發展的體型雕塑生態系統，重點闡述了影響策略選擇的因素：技術融合、患者偏好和不斷變化的臨床實踐。

體型雕塑融合了美容醫學、醫療設備工程和消費者健康需求，處於一個獨特的交匯點。本文回顧了目前的行業現狀，重點闡述了技術創新、患者期望的轉變以及臨床通訊協定的日趨成熟所帶來的影響。該領域傳統上以外科手術為主，如今已發展出多種技術，包括有創、微創和無創技術，每種技術在療效、恢復時間和風險方面各有優劣。因此，從醫療設備製造商、臨床醫生到經銷商和支付方，相關人員面臨著比以往任何時候都更加複雜的決策環境。

能量型醫療設備、病人期望和臨床技術同步發展的融合將如何重塑治療路徑、競爭格局和商業化進程？

塑形領域正經歷著一場變革性的轉變，這主要由三大趨勢共同驅動：技術日趨成熟、消費行為不斷改變以及各類醫療服務提供者臨床技能的提升。技術日趨成熟體現在能量型治療方式的逐步模組化，不僅提高了精準度，也縮短了恢復時間。因此，非侵入性和微創性治療正成為更多患者的可行選擇，從而改變了以往「手術優先」的觀念。

檢驗2025年關稅調整對塑形產業供應鏈籌資策略與定價動態的多面向影響

2025年的關稅調整將對塑形產業產生多方面的影響，改變供應商的經濟狀況、定價策略和區域供應鏈。某些進口零件和成品的關稅提高將增加依賴跨境供應關係的製造商的到岸成本，從而擠壓利潤空間，並促使製造商將生產轉移到近岸地區，同時實現採購合作夥伴的多元化。對於臨床營運商和經銷商，這些成本調整將需要他們重新審視定價模式、設備升級的資本支出計劃以及庫存策略，以應對價格的突然波動。

綜合細分分析揭示了手術類型、技術、最終用戶、應用領域和分銷管道如何共同決定了產品的採用路徑和商業化促進因素。

細分市場層面的洞察觀點了不同手術類型、技術、最終用戶、應用領域和分銷管道所帶來的差異化應用路徑、臨床工作流程和商業化策略。手術類型凸顯了三種截然不同的臨床和商業性路徑：侵入性手術在切除大量組織和取得顯著療效方面仍保持優勢，但恢復時間更長，資源需求更高。微創技術提供了一種折衷的選擇，吸引那些希望在減少恢復時間的情況下獲得顯著改善的患者。非侵入性治療在重視便利性和低風險的消費者群體中持續獲得青睞。了解哪些手術類型與醫療機構的服務模式相契合，對於設備組合定位和培訓投資至關重要。

全球各區域市場結構和文化動態導致不同的商業化優先事項、監管要求和機會概況

區域特徵導致競爭環境、法規結構和患者需求存在顯著差異，因此需要製定量身定做的商業性和臨床策略。在美洲，濃厚的美學文化、高所得人群以及密集的美容診所和醫療水療中心網路促進了新技術設備的快速普及，消費者對非侵入性和微創治療的接受度也十分顯著。然而，該地區的監管環境和支付方參與度因司法管轄區而異，因此需要製定區域性策略來檢驗臨床療效並協調報銷事宜。

在塑形產業，競爭的必然要求是技術模組化、經證實的臨床療效和卓越的服務質量，這些都是關鍵的差異化因素。

主要企業的競爭優勢可概括為三大策略重點：技術差異化、臨床證據產生以及降低臨床應用門檻的端到端服務模式。市場領導正投資於平台技術，這些技術具備模組化升級、多功能治療應用和整合分析功能，能夠可視化治療結果並支持臨床醫生的決策。中型創新者傾向於專注於細分應用和成本績效優勢，而新興參與企業則致力於突破性的人體工學設計和訂閱式服務模式，以加速市場進入。

一種切實可行的策略方法，將產品系列、臨床證據、供應鏈韌性和通路最佳化相結合，以加速產品推廣和成長。

產業領導者應採取一系列切實可行的措施，將洞察轉化為市場優勢和營運韌性。優先考慮建立產品組合策略，在核心多適應症平台與針對特定解剖區域的專用應用器和通訊協定之間取得平衡，以滿足臨床醫生和患者的需求。同時，增加對嚴謹的臨床研究和真實世界資料收集的投入，以支持索賠、完善培訓課程，並在適用情況下加快與支付方的合作。

我們採用嚴謹的混合方法調查方法，結合臨床醫師訪談、設備相關人員回饋和全面的二次分析，以檢驗可操作的產業見解。

本調查方法融合了與主要相關利益者的直接對話和系統的二次分析，以確保研究結果立足於當代實踐，並檢驗多方面證據的驗證。主要對話包括對美容診所、皮膚科診所、醫院和醫療美容中心的臨床醫生進行深度訪談，以了解他們選擇治療方案的理由、手術流程、培訓需求以及術後支持期望。這些定性研究結果與對製造商和經銷商的訪談進行了三角驗證，以了解產品藍圖、服務模式和通路經濟效益。

本文全面探討了整合產品開發、臨床檢驗和適應性商業化如何決定塑形市場的持續成功。

最後，塑形領域正處於轉折點，技術、消費者期望和臨床實踐正在融合，為以患者為中心的護理和商業性創新開闢新途徑。有創、微創和非侵入性干預措施之間的平衡將繼續影響醫療服務提供者的服務組合，而治療方法的獨特優勢以及輔助治療方法的組合將提供差異化的臨床價值。能夠將卓越的設備性能與可靠的臨床檢驗、全面的培訓和穩健的供應模式相結合的製造商和經銷商，將最有利於在各個市場獲得成功。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 人工智慧驅動的3D影像平台在個人化體型雕塑治療方案製定的應用日益廣泛
  • 針對男性美學目標量身定做的男士塑形解決方案的需求日益成長
  • 結合冷凍溶脂、射頻和雷射技術的連接通訊協定越來越受歡迎。
  • 家用非侵入式減肥設備在多個地區獲得監管部門核准後，正在擴大銷售範圍
  • 隆重介紹攜帶式手持塑身工具，可實現局部減脂和緊緻肌膚。
  • 由於社群媒體影響者和病毒式傳播的術前術後對比照片，塑形手術越來越受歡迎。
  • 透過在塑形設備製造中過渡到永續的、可生物分解的耗材，減少對環境的影響
  • 越來越重視新型非侵入性治療方法的長期臨床數據和病患報告結果
  • 將遠端醫療諮詢和數位化病患教育整合到塑形治療前後的護理路徑中
  • 亞太和拉丁美洲等新興市場（受可支配收入成長的推動）的塑形服務正在擴張。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依治療方法分類的塑形市場

  • 侵入性
  • 微創
  • 非侵入性

9. 按技術分類的塑形市場

  • 冷凍溶脂
  • 高強度聚焦超音波
  • 雷射
    • 二極體
    • Nd：YAG
  • 高頻
    • 雙極
    • 單極

第10章 以最終用戶分類的塑形市場

  • 美容診所
  • 皮膚科診所
  • 醫院
  • 醫療水療中心

第11章 依應用分類的塑形市場

  • 腹部
  • 手臂
  • 後退
  • 大腿

第12章 按通路分類的塑身產品市場

  • 直銷
  • 線上銷售
    • 數位市場
    • 製造商官方網站
  • 第三方經銷商

第13章 各地區塑形市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按群體分類的塑形市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國塑形市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • AbbVie Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Candela Medical, Inc.
    • Hologic, Inc.
    • Lumenis Ltd.
    • Cutera, Inc.
    • InMode Ltd.
    • BTL Industries, Inc.
    • Alma Lasers Limited
    • Lutronic Co., Ltd.
Product Code: MRR-1A1A064C0455

The Body Contouring Market is projected to grow by USD 983.14 million at a CAGR of 12.34% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 387.48 million
Estimated Year [2025] USD 436.35 million
Forecast Year [2032] USD 983.14 million
CAGR (%) 12.34%

A concise primer on the evolving body contouring ecosystem highlighting technology convergence patient preferences and clinical practice shifts that shape strategic choices

Body contouring occupies a unique intersection between aesthetic medicine, medical device engineering, and consumer wellness demand. This introduction frames the contemporary landscape by emphasizing the convergence of technological innovation, shifting patient expectations, and the maturation of clinical protocols. Historically grounded in surgical solutions, the field has diversified into a spectrum of invasive, minimally invasive, and non-invasive procedures, each defined by trade-offs among efficacy, recovery time, and risk profile. As a result, stakeholders ranging from device manufacturers and clinical operators to distributors and payers must navigate a more complex decision matrix than ever before.

The introduction further explains how patient demographics and lifestyle trends contribute to demand heterogeneity. Increasing consumer emphasis on minimally disruptive interventions and faster recovery has prompted clinics and medispas to expand offerings, while hospitals and dermatology practices preserve higher-acuity procedures. Concurrently, regulatory scrutiny and reimbursement considerations continue to shape technology adoption pathways and commercial models. This section sets the stage for deeper analysis by clarifying the core drivers and constraints that define strategic choices for product development, clinical protocols, and go-to-market plans.

How simultaneous advances in energy-based devices patient expectations and clinical skill integration are reshaping treatment pathways competitive dynamics and commercialization

The body contouring landscape is undergoing transformative shifts driven by three simultaneous currents: technological refinement, consumer behavior change, and an expanded clinical skill set across provider types. Technological refinement includes the progressive modularization of energy-based modalities, which has improved precision while reducing downtime. As a result, non-invasive and minimally invasive interventions have become viable options for a broader patient cohort, altering the previously dominant surgical-first mindset.

Consumer behavior change manifests through heightened expectations for safety, speed, and measurable outcomes, which has elevated the importance of validated clinical data and patient-reported outcomes in purchasing decisions. Clinics and medispas that emphasize transparent treatment protocols and demonstrable results gain competitive advantage. At the same time, clinicians in dermatology clinics and hospitals are integrating multimodal approaches that combine technologies to optimize outcomes, spurring a trend toward bundled offerings and hybrid treatment pathways.

These shifts also influence commercialization: manufacturers now prioritize ergonomic device design, treatment personalization, and service models that support training and clinical adoption. The cumulative effect is a more fluid, outcome-driven market where differentiation arises from clinical evidence, operational simplicity, and the ability to deliver consistent results across diverse patient segments.

Examining the multifaceted consequences of 2025 tariff adjustments on supply chains procurement strategies and pricing dynamics across the body contouring ecosystem

Tariff changes in 2025 exert a multifaceted influence on the body contouring industry by altering supplier economics, pricing strategies, and regional supply chains. Increased duties on certain imported components and finished devices raise landed costs for manufacturers that rely on cross-border supply relationships, which in turn pressures margins and encourages nearshoring or diversification of procurement partners. For clinical operators and distributors, these cost adjustments necessitate a re-evaluation of pricing models, capital expenditure plans for equipment upgrades, and inventory strategies to mitigate sudden price volatility.

Beyond immediate cost impacts, tariffs catalyze strategic reconfiguration. Firms with flexible manufacturing footprints accelerate investments in local assembly and certified regional partners to preserve service levels and reduce exposure to trade policy shifts. Meanwhile, procurement teams weigh the total cost of ownership more heavily, factoring in lead times, spare-parts availability, and regulatory compliance across jurisdictions. The net effect is a more deliberate approach to vendor selection, where supply resilience and service quality gain prominence alongside device performance.

Clinics, hospitals, and medispas also respond operationally: some delay non-essential capital outlays to maintain cash flow, while others re-assess bundled service pricing to offset increased equipment costs. In short, the 2025 tariff environment acts as a catalyst for supply chain reorientation, procurement sophistication, and closer alignment between manufacturers and regional partners to safeguard continuity of care and commercial momentum.

Integrated segmentation analysis revealing how procedure types technologies end users application areas and distribution channels collectively determine adoption pathways and commercialization levers

Segment-level insights reveal differentiated adoption pathways, clinical workflows, and commercialization strategies when analyzed through the lenses of procedure type, technology, end user, application area, and distribution channel. Procedure type delineates three distinct clinical and commercial routes: invasive approaches retain strength for high-volume tissue resection and definitive outcomes but carry longer recovery and higher resource intensity; minimally invasive techniques provide a middle ground that appeals to patients seeking meaningful change with reduced downtime; non-invasive treatments continue to expand appeal among consumers prioritizing convenience and lower perceived risk. Understanding which procedure types align with a provider's service model is essential for positioning device portfolios and training investments.

Technology segmentation emphasizes modality-specific dynamics. Cryolipolysis maintains strong recognition for adipocyte-targeted applications, while high intensity focused ultrasound is favored where depth-selective fat reduction and skin tightening interplay. Laser technologies, including diode and Nd:YAG variants, show differentiated utility based on target tissue characteristics and clinician preference, and radiofrequency platforms-both bipolar and monopolar-are valued for dermal remodeling and collagen induction. Device selection therefore hinges on intended application areas and complementary treatment combinations.

End-user segmentation highlights that aesthetic clinics and medispas prioritize patient throughput, shorter procedure durations, and lower device complexity, whereas dermatology clinics and hospitals place higher emphasis on clinical evidence, multi-indication versatility, and integration with existing surgical workflows. Application area segmentation underscores anatomical considerations: abdomen and thigh treatments often demand higher energy delivery and deeper penetration, while arm and back applications require tailored ergonomics and smaller applicators. Distribution channel segmentation differentiates direct sales relationships that favor service-intensive, high-touch engagements from online sales pathways that support lower-cost, self-directed procurement; within online channels, digital marketplaces and manufacturer websites play distinct roles in discovery, purchase, and after-sales support. These segmentation dimensions collectively inform product roadmaps, clinical training programs, and channel strategies that align with provider needs and patient expectations.

How distinct regional market structures and cultural dynamics create divergent commercialization priorities regulatory requirements and opportunity profiles across global territories

Regional dynamics create distinct competitive environments, regulatory frameworks, and patient demand profiles that require tailored commercial and clinical approaches. The Americas demonstrate pronounced consumer receptivity to non-invasive and minimally invasive treatments driven by strong aesthetic culture, high disposable income segments, and a dense network of aesthetic clinics and medispas that favor rapid adoption of new device technologies. In contrast, the region's regulatory landscape and payer interactions vary by jurisdiction, which necessitates localized strategies for clinical validation and reimbursement alignment.

Europe, Middle East & Africa encompasses a heterogeneous set of markets where regulatory harmonization, reimbursement norms, and cultural attitudes toward aesthetic procedures differ markedly. Western European markets often emphasize clinical evidence and device certification, leading manufacturers to invest in rigorous studies and clinician training. Emerging markets within the region show strong growth potential driven by aspirational demand and expanding clinic networks, but they require adaptable pricing and distribution models to address affordability and infrastructure constraints.

Asia-Pacific presents a dynamic mix of sophisticated urban centers and rapidly developing markets. Urban populations in several countries display high demand for minimally invasive, quick-recovery treatments, supported by advanced clinical ecosystems and strong medical tourism flows. Elsewhere in the region, growth is underpinned by rising middle-class incomes, increasing acceptance of aesthetic procedures, and expanding access to specialized providers. Across all regions, manufacturers and distributors benefit from region-specific go-to-market strategies that reflect local clinical preferences, regulatory realities, and channel structure.

Competitive imperatives emphasizing technological modularity clinical validation and service excellence as decisive differentiators in the body contouring industry

Competitive dynamics among leading companies center on three strategic priorities: technological differentiation, clinical evidence generation, and end-to-end service models that reduce friction for clinical adoption. Market leaders invest in platform technologies that enable modular upgrades, versatile treatment applicators, and integrated analytics to demonstrate outcomes and support clinician decision-making. Mid-tier innovators tend to focus on niche applications or price-performance advantages, while emerging entrants pursue disruptive ergonomics or subscription-based service models to accelerate market access.

Partnerships between device manufacturers and clinical training organizations, as well as strategic distribution alliances, are increasingly central to capturing share in a complex market. Companies that provide robust training, warranty and maintenance programs, and data-driven marketing support help clinics shorten learning curves and drive predictable outcomes. Moreover, vendor credibility is reinforced by peer-reviewed clinical studies and real-world evidence that speak to safety and efficacy across anatomical applications.

Mergers, acquisitions, and licensing arrangements continue to shape the competitive landscape, with transactions often aimed at adding complementary technologies or expanding geographic reach. For decision-makers, the competitive implication is clear: success requires aligning product roadmaps with validated clinical protocols, investing in post-sales support, and building interoperable systems that integrate easily into diverse practice settings.

A pragmatic set of strategic initiatives that align product portfolios clinical evidence supply chain resilience and channel optimization to accelerate adoption and growth

Industry leaders should adopt a set of actionable initiatives to convert insight into market advantage and operational resilience. Prioritize portfolio strategies that balance flagship, multi-indication platforms with targeted applicators and protocols tailored to specific anatomical areas to meet clinician and patient needs. Simultaneously, invest in rigorous clinical studies and real-world data collection to substantiate claims, inform training curricula, and accelerate payer engagement where applicable.

Strengthen supply chain resilience by diversifying component sources, exploring regional assembly or nearshoring options, and building predictive inventory systems that reduce stockouts while minimizing capital tied up in spares. Commercially, refine channel strategies to support both high-touch direct sales for premium, service-intensive offerings and optimized online experiences for lower-complexity devices; within online ecosystems, prioritize robust content, virtual training modules, and digital marketplaces that facilitate discovery and post-purchase support.

Finally, align go-to-market initiatives with local regulatory and cultural nuances, deploying flexible pricing and financing options in markets with affordability constraints, and establishing partnerships with leading clinical influencers to accelerate adoption. These actions, when coordinated across product, clinical, supply chain, and commercial functions, will create durable competitive advantages.

A rigorous mixed-methods research approach combining clinician interviews device stakeholder input and comprehensive secondary analysis to validate practical industry insights

The research methodology blends primary stakeholder engagement with structured secondary analysis to ensure findings are grounded in contemporary practice and validated by multiple evidence streams. Primary engagement included in-depth interviews with clinicians across aesthetic clinics, dermatology practices, hospitals, and medispas to capture treatment selection rationales, procedural workflows, training needs, and post-procedure support expectations. These qualitative insights were triangulated with manufacturer and distributor interviews to understand product roadmaps, service models, and channel economics.

Secondary analysis encompassed regulatory documents, clinical trial registries, peer-reviewed literature, and industry-standard guidance to map safety profiles, usage indications, and evolving best practices. Careful attention was given to technology-specific performance characteristics across cryolipolysis, high intensity focused ultrasound, laser modalities including diode and Nd:YAG variants, and radiofrequency platforms in bipolar and monopolar configurations. Regional regulatory frameworks and distribution modalities were analyzed to surface practical considerations for market entry and ongoing compliance.

Data synthesis applied a cross-validation approach to reconcile differing perspectives and highlight robust trends. Limitations and assumptions are transparently documented, enabling readers to adapt insights to their unique strategic contexts and to commission targeted follow-on analyses where deeper granularity is required.

Concluding perspectives on how integrated product development clinical validation and adaptive commercialization will determine sustained success in the body contouring market

In closing, the body contouring sector is positioned at an inflection point where technology, consumer expectation, and clinical practice coalesce to create new avenues for patient-centered care and commercial innovation. The balance between invasive, minimally invasive, and non-invasive interventions will continue to shape provider offerings, while modality-specific strengths and complementary treatment combinations offer differentiated clinical value. Manufacturers and distributors that couple compelling device performance with robust clinical validation, comprehensive training, and resilient supply models will be best placed to win traction across diverse markets.

Regional nuances demand localized strategies that respect regulatory regimes, payment dynamics, and cultural attitudes toward aesthetics. The 2025 tariff environment further underscores the need for procurement agility and supply chain diversification. Ultimately, organizations that integrate evidence-driven product development with pragmatic commercial execution and a clear focus on clinician support will convert market complexity into sustainable advantage and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of AI-driven 3D imaging platforms for personalized body contouring treatment planning
  • 5.2. Growing demand for male-centric body contouring solutions tailored to masculine aesthetic goals
  • 5.3. Surge in popularity of combination protocols integrating cryolipolysis with radiofrequency and laser technologies
  • 5.4. Expansion of at-home noninvasive fat reduction devices gaining regulatory approvals in multiple regions
  • 5.5. Emergence of portable handheld body sculpting tools enabling localized fat reduction and skin tightening
  • 5.6. Rising prevalence of body contouring procedures driven by social media influencers and viral before-and-after content
  • 5.7. Shift toward sustainable and biodegradable consumables in body contouring device manufacturing to reduce environmental impact
  • 5.8. Increased focus on long-term clinical data and patient-reported outcomes for new noninvasive modalities
  • 5.9. Integration of telemedicine consultations and digital patient education in pre- and posttreatment body sculpting care pathways
  • 5.10. Growth of body contouring services in emerging Asia-Pacific and Latin American markets driven by rising disposable incomes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Body Contouring Market, by Procedure Type

  • 8.1. Invasive
  • 8.2. Minimally Invasive
  • 8.3. Non Invasive

9. Body Contouring Market, by Technology

  • 9.1. Cryolipolysis
  • 9.2. High Intensity Focused Ultrasound
  • 9.3. Laser
    • 9.3.1. Diode
    • 9.3.2. Nd Yag
  • 9.4. Radiofrequency
    • 9.4.1. Bipolar
    • 9.4.2. Monopolar

10. Body Contouring Market, by End User

  • 10.1. Aesthetic Clinics
  • 10.2. Dermatology Clinics
  • 10.3. Hospitals
  • 10.4. Medispas

11. Body Contouring Market, by Application Area

  • 11.1. Abdomen
  • 11.2. Arm
  • 11.3. Back
  • 11.4. Thigh

12. Body Contouring Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online Sales
    • 12.2.1. Digital Marketplaces
    • 12.2.2. Manufacturer Website
  • 12.3. Third Party Distributors

13. Body Contouring Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Body Contouring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Body Contouring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. AbbVie Inc.
    • 16.3.2. Merz Pharma GmbH & Co. KGaA
    • 16.3.3. Candela Medical, Inc.
    • 16.3.4. Hologic, Inc.
    • 16.3.5. Lumenis Ltd.
    • 16.3.6. Cutera, Inc.
    • 16.3.7. InMode Ltd.
    • 16.3.8. BTL Industries, Inc.
    • 16.3.9. Alma Lasers Limited
    • 16.3.10. Lutronic Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BODY CONTOURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BODY CONTOURING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BODY CONTOURING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BODY CONTOURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BODY CONTOURING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BODY CONTOURING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BODY CONTOURING MARKET SIZE, BY DIODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BODY CONTOURING MARKET SIZE, BY ND YAG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BODY CONTOURING MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BODY CONTOURING MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BODY CONTOURING MARKET SIZE, BY AESTHETIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BODY CONTOURING MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDISPAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BODY CONTOURING MARKET SIZE, BY ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BODY CONTOURING MARKET SIZE, BY BACK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BODY CONTOURING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BODY CONTOURING MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BODY CONTOURING MARKET SIZE, BY DIGITAL MARKETPLACES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BODY CONTOURING MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BODY CONTOURING MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BODY CONTOURING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BODY CONTOURING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL BODY CONTOURING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL BODY CONTOURING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 331. GCC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GCC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. GCC BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. GCC BODY CONTOURING MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. GCC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 336. GCC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 337. GCC BODY CONTOURING MARKET SIZE, BY LASER, 2018-2024 (USD MILLION)
  • TABLE 338. GCC BODY CONTOURING MARKET SIZE, BY LASER, 2025-2032 (USD MILLION)
  • TABLE 339. GCC BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2018-2024 (USD MILLION)
  • TABLE 340. GCC BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, 2025-2032 (USD MILLION)
  • TABLE 341. GCC BODY CONTOURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. GCC BODY CONTOURING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. GCC BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 344. GCC BODY CONTOURING MARKET SIZE, BY APPLICATION AREA, 2025-2032 (USD MILLION)
  • TABLE 345. GCC BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 346. GCC BODY CONTOURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 347. GCC BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 348. GCC BODY CONTOURING MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD